NY A04077

Requires the New York State Department of Health to request guidance from the Centers for Medicare and Medicaid Services (CMS) within 30 days of the act taking effect

Seeks to determine whether New York can claim federal Medicaid matching funds for coverage and payment of FDA-approved evidence-based mobile medical applications

Focuses specifically on mobile medical applications designed to treat substance use disorders and opioid use disorders

Addresses the lack of a clear statutory Medicaid benefit category for software-based medical treatments that function like prescription drugs but deliver therapy through mobile applications

Responds to concerns about reduced access to in-person addiction treatment during the coronavirus pandemic and the potential for increased relapse rates